CD44 v5 domain inhibition represses the polarization of Th2 cells by interfering with the IL-4/IL-4R signaling pathway

Yang, Chun1,2,3,4; Lin, Jianhong2,3,4; Liang, Hongyan1; Xue, Li1,2,3,4; Kwart, Ariel2,3,4; Jiang, Meng2,6; Zhao, Jianjun5; Ren, Huan8; Jiang, Xiaofeng1; Munshi, Nikhil C.2,3,4,7

2021-12-01

10.1111/imcb.12491

IMMUNOLOGY AND CELL BIOLOGY   影响因子和分区

0818-9641

1440-1711

The balance between T helper type 1 (Th1) and T helper type 2 (Th2) cells is critical for both innate and acquired immune reactions. However, the precise mechanisms of T helper-cell differentiation remain unclear. As an important T-cell activation molecule, CD44 participates in the differentiation of Th1 and Th2 cells. We demonstrated that CD44 variant exon v5 (CD44 v5) is highly expressed by induced human Th2 cells. To investigate the role of the CD44 v5 domain in Th2 cell differentiation, we treated human CD4(+) T cells with anti-CD44v5 antibody and observed that the levels of phosphorylated STAT6 and GATA3 and the secretion of interleukin-4 (IL-4) were significantly decreased after the treatment. We also further found that the inhibition of Th2 differentiation was caused by the degradation of the alpha chain of IL-4 receptor (IL-4R alpha), the CD44 v5 domain colocalized with IL-4R alpha on cell surface and the degradation of IL-4R alpha increased after CD44 v5 domain blocking or ablating. Our results indicated that CD44v5 antibody treatment interrupted the interaction between CD44 v5 domain and IL-4R alpha, but the CD44 v5 domain blockage would not spoil the colocalization between IL-4R expression and T-cell receptor and the immunological synapse formation; similar results were also found in CD44v5-deficient CD4(+) T cells. In conclusion, we revealed the function of the CD44 v5 domain in Th2 cell differentiation; blocking or ablating the CD44 v5 domain could accelerate IL-4R alpha degradation and then induce the Th2 cell inhibition.

CD44v5 IL-4R Th2 polarization

SCI

英语

通讯

Department of Veterans Affairs Merit Review Award[1 I01BX001584] ; NIH[P01155258-07] ; National Natural Science Foundation of China[81301500,81171657]

Cell Biology ; Immunology

Cell Biology ; Immunology

WOS:000730795800001

WILEY

IMMUNOLOGY

Web of Science

1.Harbin Med Univ, Dept Clin Lab, Hosp 4, Harbin, Peoples R China
2.Dana Farber Canc Inst, Med Oncol, Boston, MA USA
3.Harvard Med Sch, LeBow Inst Myeloma Therapeut, Dana Farber Canc Inst, Boston, MA USA
4.Harvard Med Sch, Jerome Lipper Ctr Multiple Myeloma Res, Dana Farber Canc Inst, Boston, MA USA
5.Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH USA
6.Harbin Med Univ, Dept Gen Surg, Hosp 4, Harbin, Peoples R China
7.VA Boston Healthcare Syst, Boston, MA USA
8.Southern Univ Sci & Technol, Sch Med, Shenzhen, Peoples R China

Yang, Chun,Lin, Jianhong,Liang, Hongyan,et al. CD44 v5 domain inhibition represses the polarization of Th2 cells by interfering with the IL-4/IL-4R signaling pathway[J]. IMMUNOLOGY AND CELL BIOLOGY,2021.

Yang, Chun.,Lin, Jianhong.,Liang, Hongyan.,Xue, Li.,Kwart, Ariel.,...&Munshi, Nikhil C..(2021).CD44 v5 domain inhibition represses the polarization of Th2 cells by interfering with the IL-4/IL-4R signaling pathway.IMMUNOLOGY AND CELL BIOLOGY.

Yang, Chun,et al."CD44 v5 domain inhibition represses the polarization of Th2 cells by interfering with the IL-4/IL-4R signaling pathway".IMMUNOLOGY AND CELL BIOLOGY (2021).